FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Paolo Rovero

Research Profile

Genes & Molecular Sequences

Amino Acid Sequences

Chemicals & Drugs

Concepts & Ideas

Living Beings

Anatomy

Smooth Muscle

Phenomena

Co-author Network

Publications

TOP 3
Shashank Pandey; Anna Maria Papini; Elisa Peroni; Feliciana Real-Fernandez; Ilaria Dioni; Duccio Lambardi; Francesco Lolli; Giulia Pacini; Roberta Seraglia; Paolo Rovero
Alpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
Jean-Baptiste Chanson; Nicolas Collongues; Maria Claudia Alcaro; Francesca Barbetti; Frédéric Blanc; Marie Fleury; Francesco Lolli; Ilaria Paolini; Anna Maria Papini; Elisa Peroni; Paolo Rovero; Gabrielle Rudolf; Elizabeth Trifilieff; Jérôme de Seze
Evaluation of new immunological targets in neuromyelitis optica.
Angela De Simone; Francesca Mancini; Feliciana Real Fernàndez; Paolo Rovero; Carlo Bertucci; Vincenza Andrisano
Surface plasmon resonance, fluorescence, and circular dichroism studies for the characterization of the binding of BACE-1 inhibitors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Paolo Rovero (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Shashank Pandey; Anna Maria Papini; Elisa Peroni; Feliciana Real-Fernandez; Ilaria Dioni; Duccio Lambardi; Francesco Lolli; Giulia Pacini; Roberta Seraglia; Paolo Rovero
Alpha actinin is specifically recognized by Multiple Sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
Molecular & cellular proteomics : MCP 2013;12(2):277-82.
2013: Jean-Baptiste Chanson; Nicolas Collongues; Maria Claudia Alcaro; Francesca Barbetti; Frédéric Blanc; Marie Fleury; Francesco Lolli; Ilaria Paolini; Anna Maria Papini; Elisa Peroni; Paolo Rovero; Gabrielle Rudolf; Elizabeth Trifilieff; Jérôme de Seze
Evaluation of new immunological targets in neuromyelitis optica.
Journal of peptide science : an official publication of the European Peptide Society 2013;19(1):25-32.
2013: Angela De Simone; Francesca Mancini; Feliciana Real Fernàndez; Paolo Rovero; Carlo Bertucci; Vincenza Andrisano
Surface plasmon resonance, fluorescence, and circular dichroism studies for the characterization of the binding of BACE-1 inhibitors.
Analytical and bioanalytical chemistry 2013;405(2-3):827-35.
2012: Shashank Pandey; Ilaria Paolini; Anna Maria Papini; Elisa Peroni; Maria Claudia Alcaro; Francesca Barbetti; Alfonso Carotenuto; Sara Di Marino; Anna Maria D'Ursi; Ettore Novellino; Mario Scrima; Paolo Rovero
Designed glucopeptides mimetics of myelin protein epitopes as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis.
Journal of medicinal chemistry 2012;55(23):10437-47.
2012: Mario Scrima; Chiara Testa; Michael Chorev; Sara Di Marino; Manuela Grimaldi; Anna Maria Papini; Paolo Rovero; Anna Maria D'Ursi
Solvent independent conformational propensities of [1,2,3]triazolyl-bridged parathyroid hormone-related peptide-derived cyclo-nonapeptide analogues.
Biopolymers 2012;98(6):535-45.
2012: Feliciana Real-Fernández; Mario Chelli; Francesco Lolli; Anna Maria Papini; Irene Passalacqua; Elisa Peroni; Paolo Rovero
Glycopeptide-based antibody detection in multiple sclerosis by surface plasmon resonance.
Sensors (Basel, Switzerland) 2012;12(5):5596-607.
2012: Chiara Testa; Paolo Rovero; Mario Chelli; Claudio De Felice; Joussef Hayek; Giuseppe Latini; Francesca Nuti; Anna Maria Papini
Di-(2-ethylhexyl) phthalate and autism spectrum disorders.
ASN neuro 2012;4(4):223-9.
2011: Fabio Rizzolo; Paolo Rovero; Chiara Testa; Mario Chelli; Michael Chorev; Duccio Lambardi; Anna Maria Papini
Conventional and microwave-assisted SPPS approach: a comparative synthesis of PTHrP(1-34)NH(2).
Journal of peptide science : an official publication of the European Peptide Society 2011;17(10):708-14.
2011: Francesca Gori; Barbara Mulinacci; Lara Massai; Carlo Avolio; Mariantonietta Caragnano; Elisa Peroni; Silvia Lori; Mario Chelli; Anna Maria Papini; Paolo Rovero; Francesco Lolli
IgG and IgM antibodies to the refolded MOG(1-125) extracellular domain in humans.
Journal of neuroimmunology 2011;233(1-2):216-20.
2011: Eva Boenzli; Valentino Cattori; Norman Flynn; Bernd Gutte; Regina Hofmann-Lehmann; Marina L Meli; Céline Robert-Tissot; Paolo Rovero; Giuseppina Sabatino; Hans Lutz
In vitro inhibition of feline leukaemia virus infection by synthetic peptides derived from the transmembrane domain.
Antiviral therapy 2011;16(6):905-13.
2010: Francesca Nuti; Elisa Peroni; Feliciana Real-Fernández; M Angeles Bonache; Alexandra Le Chevalier-Isaad; Mario Chelli; Nadège Lubin-Germain; Jacques Uziel; Paolo Rovero; Francesco Lolli; Anna Maria Papini
Posttranslationally modified peptides efficiently mimicking neoantigens: a challenge for theragnostics of autoimmune diseases.
Biopolymers 2010;94(6):791-9.
2009: Paolo Grieco; Alfonso Carotenuto; Pietro Campiglia; Isabel Gomez-Monterrey; Luigia Auriemma; Marina Sala; Cristina Marcozzi; Roberta d'Emmanuele di Villa Bianca; Diego Brancaccio; Paolo Rovero; Paolo Santicioli; stefania meini; Carlo A Maggi; Ettore Novellino
New insight into the binding mode of peptide ligands at Urotensin-II receptor: structure-activity relationships study on P5U and urantide.
Journal of medicinal chemistry 2009;52(13):3927-40.
2009: Alexandra Le Chevalier Isaad; Anna Maria Papini; Michael Chorev; Paolo Rovero
Side chain-to-side chain cyclization by click reaction.
Journal of peptide science : an official publication of the European Peptide Society 2009;15(7):451-4.
2009: Stefano Carganico; Paolo Rovero; Jose A Halperin; Anna Maria Papini; Michael Chorev
Building blocks for the synthesis of post-translationally modified glycated peptides and proteins.
Journal of peptide science : an official publication of the European Peptide Society 2009;15(2):67-71.
2009: Ma Angeles Bonache; Alexandra Le Chevalier; Francesca Nuti; Elisa Peroni; Mario Chelli; Paolo Rovero; Anna Maria Papini
Ribose building block for the synthesis of glycopeptides for fishing out antibodies in autoimmune diseases.
Advances in experimental medicine and biology 2009;611():441-2.
2009: Francesca Nuti; Barbara Mulinacci; Elisa Peroni; Maria C Alcaro; Ilaria Paolini; Francesco Benedetti; Alfonso Carotenuto; Francis Ciolli; Francesco Lolli; Mario Chelli; Paolo Rovero; Anna Maria Papini
Studies for identification of the minimal epitope(s) mimicked by the synthetic glucopeptide CSF114(Glc).
Advances in experimental medicine and biology 2009;611():431-2.
2009: Elisa Peroni; Marta Tontini; Barbara Mulinacci; Mario Chelli; Francesco Lolli; Paolo Rovero; Anna Maria Papini
A glycopeptide-based technique for selective antibody purification.
Advances in experimental medicine and biology 2009;611():369-70.
2009: Francesca Gori; Barbara Mulinacci; Eva Bonchi; Mario Chelli; Francesco Lolli; Anna Maria Papini; Paolo Rovero
Semi-synthetic strategies to obtain glucosylated MOG to identify antibodies as biomarkers in multiple sclerosis disease.
Advances in experimental medicine and biology 2009;611():327-8.
2009: Sonia Cantel; Jose A Halperin; Michael Chorev; Mario Scrima; Anna Maria D'Ursi; Jay J Levy; Richard D Dimarchi; Alexandra Le Chevalier; Paolo Rovero; Anna Maria Papini
Side chain-to-side chain cyclization by intramolecular click reaction--building blocks, solid phase synthesis and conformational characterization.
Advances in experimental medicine and biology 2009;611():175-6.
2008: Alfonso Carotenuto; Maria Claudia Alcaro; Maria Rosaria Saviello; Elisa Peroni; Francesca Nuti; Anna Maria Papini; Ettore Novellino; Paolo Rovero
Designed glycopeptides with different beta-turn types as synthetic probes for the detection of autoantibodies as biomarkers of multiple sclerosis.
Journal of medicinal chemistry 2008;51(17):5304-9.
2008: Sonia Cantel; Alexandra Le Chevalier Isaad; Mario Scrima; Jay J Levy; Richard D Dimarchi; Paolo Rovero; Jose A Halperin; Anna Maria D'Ursi; Anna Maria Papini; Michael Chorev
Synthesis and conformational analysis of a cyclic peptide obtained via i to i+4 intramolecular side-chain to side-chain azide-alkyne 1,3-dipolar cycloaddition.
The Journal of organic chemistry 2008;73(15):5663-74.
2008: Carla Esposito; Mario Scrima; Alfonso Carotenuto; Annamaria Tedeschi; Paolo Rovero; Gerardino D'Errico; Anna Maria Malfitano; Maurizio Bifulco; Anna Maria D'Ursi
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2',3'-cyclic nucleotide-3'-phosphodiesterase.
Biochemistry 2008;47(1):308-19.
2007: Simone Giannecchini; Anna Maria D'Ursi; Carla Esposito; Mario Scrima; Elisa Zabogli; Giulia Freer; Paolo Rovero; Mauro Bendinelli
Antibodies generated in cats by a lipopeptide reproducing the membrane-proximal external region of the feline immunodeficiency virus transmembrane enhance virus infectivity.
Clinical and vaccine immunology : CVI 2007;14(8):944-51.
2007: Francesca Nuti; Ilaria Paolini; Francesca Cardona; Mario Chelli; Francesco Lolli; Alberto Brandi; Andrea Goti; Paolo Rovero; Anna Maria Papini
Fmoc-protected iminosugar modified asparagine derivatives as building blocks for glycomimetics-containing peptides.
Bioorganic & medicinal chemistry 2007;15(12):3965-73.
2007: Stefania Albrizio; Laura Giusti; Gerardino D'Errico; Carla Esposito; Francesca Porchia; Giuseppe Caliendo; Ettore Novellino; Maria R Mazzoni; Paolo Rovero; Anna Maria D'Ursi
Driving forces in the delivery of penetratin conjugated G protein fragment.
Journal of medicinal chemistry 2007;50(7):1458-64.
2006: Carla Esposito; Annamaria Tedeschi; Mario Scrima; Gerardino D'Errico; M Francesca Ottaviani; Paolo Rovero; Anna Maria D'Ursi
Exploring interaction of beta-amyloid segment (25-35) with membrane models through paramagnetic probes.
Journal of peptide science : an official publication of the European Peptide Society 2006;12(12):766-74.
2006: Carla Esposito; Gerardino D'Errico; Maria Rosaria Armenante; Simone Giannecchini; Mauro Bendinelli; Paolo Rovero; Anna Maria D'Ursi
Physicochemical characterization of a peptide deriving from the glycoprotein gp36 of the feline immunodeficiency virus and its lipoylated analogue in micellar systems.
Biochimica et biophysica acta 2006;1758(10):1653-61.
2006: Alfonso Carotenuto; Anna Maria D'Ursi; Barbara Mulinacci; Ilaria Paolini; Francesco Lolli; Anna Maria Papini; Ettore Novellino; Paolo Rovero
Conformation-activity relationship of designed glycopeptides as synthetic probes for the detection of autoantibodies, biomarkers of multiple sclerosis.
Journal of medicinal chemistry 2006;49(17):5072-9.
2006: Lucia Becucci; Reyes Romero León; Maria Rosa Moncelli; Paolo Rovero; Rolando Guidelli
Electrochemical investigation of melittin reconstituted into a mercury-supported lipid bilayer.
Langmuir : the ACS journal of surfaces and colloids 2006;22(15):6644-50.
2006: Francesco Lolli; Paolo Rovero; Mario Chelli; Anna Maria Papini
Toward biomarkers in multiple sclerosis: new advances.
Expert review of neurotherapeutics 2006;6(5):781-94.
2006: Anna Maria D'Ursi; Simone Giannecchini; Carla Esposito; Maria Claudia Alcaro; Olimpia Sichi; Maria Rosaria Armenante; Alfonso Carotenuto; Anna Maria Papini; Mauro Bendinelli; Paolo Rovero
Development of antiviral fusion inhibitors: short modified peptides derived from the transmembrane glycoprotein of feline immunodeficiency virus.
Chembiochem : a European journal of chemical biology 2006;7(5):774-9.
2006: Anna Maria D'Ursi; Laura Giusti; Stefania Albrizio; Francesca Porchia; Carla Esposito; Giuseppe Caliendo; Claudia Gargini; Ettore Novellino; Antonio Lucacchini; Paolo Rovero; Maria R Mazzoni
A membrane-permeable peptide containing the last 21 residues of the G alpha(s) carboxyl terminus inhibits G(s)-coupled receptor signaling in intact cells: correlations between peptide structure and biological activity.
Molecular pharmacology 2006;69(3):727-36.
2006: Alfonso Carotenuto; Paolo Grieco; Paolo Rovero; Ettore Novellino
Urotensin-II receptor antagonists.
Current medicinal chemistry 2006;13(3):267-75.
2005: Zbigniew J Kamiński; Beata Kolesińska; Justyna Kolesińska; Giuseppina Sabatino; Mario Chelli; Paolo Rovero; Michał Błaszczyk; Marek L Główka; Anna Maria Papini
N-triazinylammonium tetrafluoroborates. A new generation of efficient coupling reagents useful for peptide synthesis.
Journal of the American Chemical Society 2005;127(48):16912-20.
2005: Paolo Grieco; Alfonso Carotenuto; Pietro Campiglia; Luciana Marinelli; Teresa Lama; Riccardo Patacchini; Paolo Santicioli; Carlo A Maggi; Paolo Rovero; Ettore Novellino
Urotensin-II receptor ligands. From agonist to antagonist activity.
Journal of medicinal chemistry 2005;48(23):7290-7.
2005: Francesco Lolli; Benedetta Mazzanti; Marta Pazzagli; Elisa Peroni; Maria Claudia Alcaro; Giuseppina Sabatino; Roberta Lanzillo; Vincenzo Brescia Morra; Lucio Santoro; Claudio Gasperini; Simona Galgani; Mario Milco D'Elios; Valentina Zipoli; Stefano Sotgiu; Maura Pugliatti; Paolo Rovero; Mario Chelli; Anna Maria Papini
The glycopeptide CSF114(Glc) detects serum antibodies in multiple sclerosis.
Journal of neuroimmunology 2005;167(1-2):131-7.
2005: Stefania Albrizio; Giuseppe Caliendo; Gerardino D'Errico; Ettore Novellino; Paolo Rovero; Anna Maria D'Ursi
Galphas protein C-terminal alpha-helix at the interface: does the plasma membrane play a critical role in the Galphas protein functionality?
Journal of peptide science : an official publication of the European Peptide Society 2005;11(10):617-26.
2005: Francesco Lolli; Paolo Rovero; Mario Chelli; Anna Maria Papini
Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
Neurology 2005;65(5):781-2; author reply 781-2.
2005: Francesco Lolli; Barbara Mulinacci; Alfonso Carotenuto; Bruno Bonetti; Giuseppina Sabatino; Benedetta Mazzanti; Anna Maria D'Ursi; Ettore Novellino; Marta Pazzagli; Laura Lovato; Maria Claudia Alcaro; Elisa Peroni; Maria C Pozo-Carrero; Francesca Nuti; Luca Battistini; Giovanna Borsellino; Mario Chelli; Paolo Rovero; Anna Maria Papini
An N-glucosylated peptide detecting disease-specific autoantibodies, biomarkers of multiple sclerosis.
Proceedings of the National Academy of Sciences of the United States of America 2005;102(29):10273-8.
2005: Simone Giannecchini; Maria Claudia Alcaro; Patrizia Isola; Olimpia Sichi; Mauro Pistello; Anna Maria Papini; Paolo Rovero; Mauro Bendinelli
Feline immunodeficiency virus plasma load reduction by a retroinverso octapeptide reproducing the Trp-rich motif of the transmembrane glycoprotein.
Antiviral therapy 2005;10(5):671-80.
2004: Alfonso Carotenuto; Paolo Grieco; Ettore Novellino; Paolo Rovero
Urotensin-II receptor peptide agonists.
Medicinal research reviews 2004;24(5):577-88.
2004: Giulia Freer; Simone Giannecchini; Alain Tissot; Martin F Bachmann; Paolo Rovero; Pierre Francoise Serres; Mauro Bendinelli
Dissection of seroreactivity against the tryptophan-rich motif of the feline immunodeficiency virus transmembrane glycoprotein.
Virology 2004;322(2):360-9.
2004: Simone Giannecchini; Mauro Pistello; Barbara Del Santo; Paolo Rovero; Olimpia Sichi; Mauro Bendinelli
Changes in the SU can modulate the susceptibility of feline immunodeficiency virus to TM-derived entry inhibitors.
The new microbiologica 2004;27(2 Suppl 1):77-84.
2004: Maria Claudia Alcaro; Giuseppina Sabatino; Jacques Uziel; Mario Chelli; Mauro Ginanneschi; Paolo Rovero; Anna Maria Papini
On-resin head-to-tail cyclization of cyclotetrapeptides: optimization of crucial parameters.
Journal of peptide science : an official publication of the European Peptide Society 2004;10(4):218-28.
2004: Paolo Grieco; Paolo Rovero; Ettore Novellino
Recent structure-activity studies of the peptide hormone urotensin-II, a potent vasoconstrictor.
Current medicinal chemistry 2004;11(8):969-79.
2004: Alfonso Carotenuto; Paolo Grieco; Pietro Campiglia; Ettore Novellino; Paolo Rovero
Unraveling the active conformation of urotensin II.
Journal of medicinal chemistry 2004;47(7):1652-61.
2004: Simone Giannecchini; Francesca Bonci; Mauro Pistello; Donatella Matteucci; Olimpia Sichi; Paolo Rovero; Mauro Bendinelli
The membrane-proximal tryptophan-rich region in the transmembrane glycoprotein ectodomain of feline immunodeficiency virus is important for cell entry.
Virology 2004;320(1):156-66.
2003: Riccardo Patacchini; Paolo Santicioli; Sandro Giuliani; Paolo Grieco; Ettore Novellino; Paolo Rovero; Carlo Alberto Maggi
Urantide: an ultrapotent urotensin II antagonist peptide in the rat aorta.
British journal of pharmacology 2003;140(7):1155-8.
2003: Maria Claudia Alcaro; Elisa Peroni; Paolo Rovero; Anna Maria Papini
Synthetic peptides in the diagnosis of HIV infection.
Current protein & peptide science 2003;4(4):285-90.
2003: Francesco Lolli; Benedetta Mazzanti; Paolo Rovero; Anna Maria Papini
Synthetic peptides in the diagnosis of neurological diseases.
Current protein & peptide science 2003;4(4):277-84.
2003: Margherita Ruoppolo; Stefania Orrù; Alfonsina D'Amato; Simona Francese; Paolo Rovero; Gennaro Marino; Carla Esposito
Analysis of transglutaminase protein substrates by functional proteomics.
Protein science : a publication of the Protein Society 2003;12(6):1290-7.
2003: Anna Maria D'Ursi; Simone Giannecchini; Armida Di Fenza; Carla Esposito; Maria Rosaria Armenante; Alfonso Carotenuto; Mauro Bendinelli; Paolo Rovero
Retroinverso analogue of the antiviral octapeptide C8 inhibits feline immunodeficiency virus in serum.
Journal of medicinal chemistry 2003;46(10):1807-10.
2003: Simone Giannecchini; Armida Di Fenza; Anna Maria D'Ursi; Donatella Matteucci; Paolo Rovero; Mauro Bendinelli
Antiviral activity and conformational features of an octapeptide derived from the membrane-proximal ectodomain of the feline immunodeficiency virus transmembrane glycoprotein.
Journal of virology 2003;77(6):3724-33.
2003: Paolo Grieco; Stefania Albrizio; Anna Maria D'Ursi; Laura Giusti; Maria R Mazzoni; Ettore Novellino; Paolo Rovero
A structure-activity relationship study on position-2 of the Galpha(s) C-terminal peptide able to inhibit G(s) activation by A2A adenosine receptor.
European journal of medicinal chemistry 2003;38(1):13-8.
2002: Anna Maria D'Ursi; Stefania Albrizio; Armida Di Fenza; Orlando Crescenzi; Alfonso Carotenuto; Delia Picone; Ettore Novellino; Paolo Rovero
Structural studies on Hgr3 orphan receptor ligand prolactin-releasing peptide.
Journal of medicinal chemistry 2002;45(25):5483-91.
2002: Paolo Grieco; Alfonso Carotenuto; Riccardo Patacchini; Carlo A Maggi; Ettore Novellino; Paolo Rovero
Design, synthesis, conformational analysis, and biological studies of urotensin-II lactam analogues.
Bioorganic & medicinal chemistry 2002;10(12):3731-9.
2002: Paolo Grieco; Alfonso Carotenuto; Pietro Campiglia; Enrico Zampelli; Riccardo Patacchini; Carlo A Maggi; Ettore Novellino; Paolo Rovero
A new, potent urotensin II receptor peptide agonist containing a Pen residue at the disulfide bridge.
Journal of medicinal chemistry 2002;45(20):4391-4.
2002: Anna Maria Dursi; Stefania Albrizio; Giovanni Greco; Sonia Mazzeo; Maria R Mazzoni; Ettore Novellino; Paolo Rovero
Conformational analysis of the Galpha(s) protein C-terminal region.
Journal of peptide science : an official publication of the European Peptide Society 2002;8(8):476-88.
2002: Assunta Napolitano; Ines Bruno; Paolo Rovero; Rut Lucas; Miguel Payà Peris; Luigi Gomez-Paloma; Raffaele Riccio
Synthesis and biological properties of the seven alanine-modified analogues of the marine cyclopeptide hymenamide C.
Journal of peptide science : an official publication of the European Peptide Society 2002;8(8):407-17.
2001: Alfonso Carotenuto; Anna Maria D'Ursi; E Nardi; Anna Maria Papini; Paolo Rovero
Conformational analysis of a glycosylated human myelin oligodendrocyte glycoprotein peptide epitope able to detect antibody response in multiple sclerosis.
Journal of medicinal chemistry 2001;44(14):2378-81.
2001: Mauro Pistello; A Morrica; Fabrizio Maggi; Marialinda Vatteroni; Giulia Freer; Claudia Fornai; F Casula; Santino Marchi; Pietro Ciccorossi; Paolo Rovero; Mauro Bendinelli
TT virus levels in the plasma of infected individuals with different hepatic and extrahepatic pathology.
Journal of medical virology 2001;63(2):189-95.
2001: Paolo Rovero; M Pellegrini; Armida Di Fenza; stefania meini; Laura Quartara; Carlo Alberto Maggi; Fernando Formaggio; C Toniolo; D F Mierke
Agonist activity at the kinin B1 receptor: structural requirements of the central tetrapeptide.
Journal of medicinal chemistry 2001;44(2):274-8.
2000: Stefania Albrizio; Anna Maria D'Ursi; Caterina Fattorusso; C Galoppini; Giovanni Greco; Maria R Mazzoni; Ettore Novellino; Paolo Rovero
Conformational studies on a synthetic C-terminal fragment of the alpha subunit of G(S) proteins.
Biopolymers 2000;54(3):186-94.
2000: Maria R Mazzoni; Simone Taddei; Laura Giusti; Paolo Rovero; C Galoppini; Anna Maria D'Ursi; Stefania Albrizio; Antonio Triolo; Ettore Novellino; Giovanni Greco; Antonio Lucacchini; Heidi E Hamm
A galpha(s) carboxyl-terminal peptide prevents G(s) activation by the A(2A) adenosine receptor.
Molecular pharmacology 2000;58(1):226-36.
1999: Evaristo Peggion; Stefano Mammi; Elisabetta Schievano; Roberto P Revoltella; C Galoppini; Paolo Rovero
Design, synthesis, and conformational studies of the hGM-CSF derived peptide (13-27)-Gly-(75-87).
Biopolymers 1999;50(5):545-54.
1999: Maria Pellegrini; M Tancredi; Paolo Rovero; Dale F Mierke
Probing the topological arrangement of the N- and C-terminal residues of bradykinin for agonist activity at the B1 receptor.
Journal of medicinal chemistry 1999;42(17):3369-77.
1999: C Galoppini; Laura Giusti; Marco Macchia; Mahmoud Hamdan; Maria R Mazzoni; F Calvani; Paolo Rovero
Synthesis and structure-activity relationship studies of new endothelin pseudopeptide analogues containing alkyl spacers.
Farmaco (Società chimica italiana : 1989) 1999;54(4):213-7.
1999: C Galoppini; stefania meini; M Tancredi; Armida Di Fenza; Antonio Triolo; Laura Quartara; Carlo Alberto Maggi; Fernando Formaggio; C Toniolo; S Mazzucco; Anna Maria Papini; Paolo Rovero
A new class of pseudopeptide antagonists of the kinin B1 receptor containing alkyl spacers.
Journal of medicinal chemistry 1999;42(3):409-14.
1998: Marco Macchia; Silvia Barontini; Francesca Ceccarelli; C Galoppini; Laura Giusti; Mahmoud Hamdan; Antonio Lucacchini; Adriano Martinelli; E Menchini; Maria R Mazzoni; Roberto P Revoltella; F Romagnoli; Paolo Rovero
Toward the rational development of peptidomimetic analogs of the C-terminal endothelin hexapeptide: development of a theoretical model.
Farmaco (Società chimica italiana : 1989) 1998;53(8-9):545-56.
1998: C Massi; E Indino; C Lami; A Fissi; Osvaldo Pieroni; C La Rosa; F Esposito; C Galoppini; Paolo Rovero; Patrizia Bandecchi; Mauro Bendinelli; Carlo Garzelli
The antiviral activity of a synthetic peptide derived from the envelope SU glycoprotein of feline immunodeficiency virus maps in correspondence of an amphipathic helical segment.
Biochemical and biophysical research communications 1998;246(1):160-5.
1998: E Cassano; C Galoppini; Laura Giusti; Mahmoud Hamdan; Marco Macchia; Maria R Mazzoni; E Menchini; Stefano Pegoraro; Paolo Rovero
A structure-activity study of a C-terminal endothelin analogue.
Folia biologica 1998;44(1):11-4.
1998: Paolo Rovero; C Galoppini; Leopoldo Laricchia-Robbio; Maria R Mazzoni; Roberto P Revoltella
Structure-activity analysis of C-terminal endothelin analogues.
Journal of cardiovascular pharmacology 1998;31 Suppl 1():S251-4.
1997: Stella Fiori; Stefano Mammi; Evaristo Peggion; Paolo Rovero; Stefano Pegoraro; Roberto P Revoltella
Conformation of four peptides corresponding to the alpha-helical segments of human GM-CSF.
Journal of peptide science : an official publication of the European Peptide Society 1997;3(5):336-46.
1997: N Noli; M Gurrath; Paolo Rovero; Stefano Pegoraro; Roberto P Revoltella; Elisabetta Schievano; Stefano Mammi; Evaristo Peggion
Design, synthesis and conformational analysis of hGM-CSF(13-31)-Gly-Pro-Gly-(103-116).
Journal of peptide science : an official publication of the European Peptide Society 1997;3(5):323-35.
1997: Leopoldo Laricchia-Robbio; S Moscato; Alessandra Guidi; S Viganò; Paolo Rovero; Roberto P Revoltella
Detection and epitope mapping of immunoreactive human endothelin-1 using ELISA and a surface plasmon resonance-based biosensor.
Biosensors & bioelectronics 1997;12(8):765-78.
1997: Monica Dettin; Stefano Pegoraro; Paolo Rovero; Silvio Bicciato; Alessandro Bagno; Carlo Di Bello
SPPS of difficult sequences. A comparison of chemical conditions, synthetic strategies and on-line monitoring.
The journal of peptide research : official journal of the American Peptide Society 1997;49(1):103-11.
1996: Leopoldo Laricchia-Robbio; B Liedberg; T Platou-Vikinge; Paolo Rovero; P Beffy; Roberto P Revoltella
Mapping of monoclonal antibody- and receptor-binding domains on human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) using a surface plasmon resonance-based biosensor.
Hybridoma 1996;15(5):343-50.
1996: S Lombardi; C Massi; E Indino; C La Rosa; Paola Mazzetti; M L Falcone; Paolo Rovero; A Fissi; Osvaldo Pieroni; P Bandecchi; F Esposito; F Tozzini; Mauro Bendinelli; Carlo Garzelli
Inhibition of feline immunodeficiency virus infection in vitro by envelope glycoprotein synthetic peptides.
Virology 1996;220(2):274-84.
1996: V Di Bartolo; A Danè; E Cassano; S Viganò; E Chiello; D Verniani; P Beffy; Stefano Pegoraro; Mahmoud Hamdan; Paolo Rovero; Roberto P Revoltella
Binding of human GM-CSF to synthetic peptides of the alpha subunit of its receptor.
Journal of receptor and signal transduction research 1996;16(1-2):77-92.
1996: Mahmoud Hamdan; O Curcuruto; S Vigano; Paolo Rovero
Investigation of newly synthesized peptides by capillary zone electrophoresis/electrospray mass spectrometry.
Rapid communications in mass spectrometry : RCM 1996;10(9):1128-32.
1995: Paolo Rovero; S Viganò; Stefano Pegoraro; Roberto P Revoltella; D Riganelli; Doriana Fruci; G Greco; R H Butler; N Tanigaki
Augmentation of the affinity of HLA class I-binding peptides lacking primary anchor residues by manipulation of the secondary anchor residues.
Journal of peptide science : an official publication of the European Peptide Society 1995;1(4):266-73.
1995: L Casté; Maurizio Zandomeneghi; J L Houben; Paolo Rovero; Stefano Pegoraro; P R Revoltella; J C Brochon
CD and fluorescence studies of the human granulocyte-macrophage colony-stimulating factor and related peptide conformations in aqueous solution.
Biopolymers 1995;36(1):1-8.
1995: Laura Quartara; Paolo Rovero; Carlo Alberto Maggi
Peptide-based tachykinin NK2 receptor antagonists.
Medicinal research reviews 1995;15(2):139-55.
1995: L Caponi; Stefano Pegoraro; V Di Bartolo; Paolo Rovero; Roberto P Revoltella; Stefano Bombardieri
Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA.
Journal of immunological methods 1995;179(2):193-202.
1995: stefania meini; Riccardo Patacchini; Alessandro Lecci; C Poulos; Paolo Rovero; Carlo Alberto Maggi
GR 73,632 and [Glu(OBzl)11]substance P are selective agonists for the septide-sensitive tachykinin NK1 receptor in the rat urinary bladder.
Neuropeptides 1995;28(2):99-106.
1995: Aleksi Sedo; Stefano Pegoraro; Paolo Rovero; Roberto P Revoltella
A new endothelin C-terminal analogue IBDP 064 antagonizes endothelin-3-induced cell proliferation.
Folia biologica 1995;41(2):97-105.
1995: Doriana Fruci; R H Butler; G Greco; Paolo Rovero; L Pazmany; E Vigneti; Roberto Tosi; N Tanigaki
Differences in peptide-binding specificity of two ankylosing spondylitis-associated HLA-B27 subtypes.
Immunogenetics 1995;42(2):123-8.
1994: P Beffy; Paolo Rovero; V Di Bartolo; Leopoldo Laricchia-Robbio; A Dané; Stefano Pegoraro; F Bertolero; Roberto P Revoltella
An immunodominant epitope in a functional domain near the N-terminus of human granulocyte-macrophage colony-stimulating factor identified by cross-reaction of synthetic peptides with neutralizing anti-protein and anti-peptide antibodies.
Hybridoma 1994;13(6):457-68.
1994: C Poulos; M Antoniou; R Patacchini; C A Maggi; Stefano Pegoraro; Paolo Rovero
Synthesis and biological activity of NK1 substance P selective agonists by modifying the methionyl residue.
Neuropeptides 1994;27(1):27-9.
1994: Paolo Rovero; D Riganelli; Doriana Fruci; S Viganò; S Pegoŕaro; Roberto P Revoltella; G Greco; R Butler; S Clementi; N Tanigaki
The importance of secondary anchor residue motifs of HLA class I proteins: a chemometric approach.
Molecular immunology 1994;31(7):549-54.
1994: N Tanigaki; Doriana Fruci; E Vigneti; G Starace; Paolo Rovero; M Londei; R H Butler; Roberto Tosi
The peptide binding specificity of HLA-B27 subtypes.
Immunogenetics 1994;40(3):192-8.
1994: C Poulos; M Antoniou; R Patacchini; C A Maggi; Paolo Rovero
Synthesis and biological activity of NK1 tachykinin antagonists not containing D-residues.
Neuropeptides 1994;26(1):55-7.
1993: Sandro Giuliani; Riccardo Patacchini; G Barbanti; Damiano Turini; Paolo Rovero; Laura Quartara; A Giachetti; Carlo Alberto Maggi
Characterization of the tachykinin neurokinin-2 receptor in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors.
The Journal of pharmacology and experimental therapeutics 1993;267(2):590-5.
1993: Doriana Fruci; Paolo Rovero; Giuliana Falasca; Alberto Chersi; R Sorrentino; R Butler; N Tanigaki; Roberto Tosi
Anchor residue motifs of HLA class-I-binding peptides analyzed by the direct binding of synthetic peptides to HLA class I alpha chains.
Human immunology 1993;38(3):187-92.
1993: Doriana Fruci; Paolo Rovero; R H Butler; R Sorrentino; Roberto Tosi; N Tanigaki
HLA class I binding of synthetic nonamer peptides carrying major anchor residue motifs of HLA-B27 (B*2705)-binding peptides.
Immunogenetics 1993;38(1):41-6.
1993: Riccardo Patacchini; Laura Quartara; Paolo Rovero; C Goso; Carlo Alberto Maggi
Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties.
The Journal of pharmacology and experimental therapeutics 1993;264(1):17-21.
1992: Carlo Alberto Maggi; Sandro Giuliani; Riccardo Patacchini; Laura Quartara; Paolo Rovero; Anna-Rita Renzetti; J Mizrahi; A Giachetti
Heterogeneity of tachykinin NK-2 receptors in rabbit, guinea-pig and human smooth muscles.
Neuropeptides 1992;23(3):181-6.
1992: Roberto P Revoltella; Paolo Rovero; P Beffy; M Dal Monte
Structure-function analysis of human granulocyte-macrophage colony stimulating factor using synthetic peptides and antibodies.
Pharmacological research : the official journal of the Italian Pharmacological Society 1992;26 Suppl 2():192-3.
1992: Carlo Alberto Maggi; Riccardo Patacchini; M Astolfi; Paolo Rovero; A Giachetti; P L Van Giersbergen
Affinity of R 396, an NK-2 tachykinin receptor antagonist, for NK-2 receptors in preparations from different species.
Neuropeptides 1992;22(2):93-8.
1992: Riccardo Patacchini; Paolo Santicioli; M Astolfi; Paolo Rovero; G Viti; Carlo Alberto Maggi
Activity of peptide and non-peptide antagonists at peripheral NK1 receptors.
European journal of pharmacology 1992;215(1):93-8.
1992: Laura Quartara; R Patacchini; Sandro Giuliani; Anna-Rita Renzetti; Paolo Rovero; C A Maggi
N-terminal truncated analogs of men 10376 as tachykinin NK-2 receptor antagonists.
Life sciences 1992;51(25):1929-36.
1992: Paolo Rovero; Laura Quartara; M Astolfi; Riccardo Patacchini; A Giachetti; C A Maggi
Structure-activity study of the C-terminal residue of MEN 10207 tachykinin antagonist.
Peptides 1992;13(1):207-8.
1991: Sandro Giuliani; G Barbanti; Damiano Turini; Laura Quartara; Paolo Rovero; A Giachetti; Carlo Alberto Maggi
NK2 tachykinin receptors and contraction of circular muscle of the human colon: characterization of the NK2 receptor subtype.
European journal of pharmacology 1991;203(3):365-70.
1991: Paolo Rovero; M Astolfi; Anna-Rita Renzetti; R Patacchini; A Giachetti; C A Maggi
Role of D-tryptophan for affinity of MEN 10207 tachykinin antagonist at NK2 receptors.
Peptides 1991;12(5):1015-8.
1991: Riccardo Patacchini; M Astolfi; Laura Quartara; Paolo Rovero; A Giachetti; Carlo Alberto Maggi
Further evidence for the existence of NK2 tachykinin receptor subtypes.
British journal of pharmacology 1991;104(1):91-6.
1991: luigi abelli; C A Maggi; Paolo Rovero; E Del Bianco; D Regoli; G Drapeau; A Giachetti
Effect of synthetic tachykinin analogues on airway microvascular leakage in rats and guinea-pigs: evidence for the involvement of NK-1 receptors.
Journal of autonomic pharmacology 1991;11(4):267-75.
1991: Carlo Alberto Maggi; Sandro Giuliani; L Ballati; Alessandro Lecci; Stefano Manzini; Riccardo Patacchini; Anna-Rita Renzetti; Paolo Rovero; Laura Quartara; A Giachetti
In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376.
The Journal of pharmacology and experimental therapeutics 1991;257(3):1172-8.
1991: Paolo Rovero; Laura Quartara; G Fabbri
Solid-phase synthesis of neurokinin A antagonists. Comparison of the Boc and Fmoc methods.
International journal of peptide and protein research 1991;37(2):140-4.
1991: luigi abelli; Filomena Nappi; Carlo Alberto Maggi; Paolo Rovero; M Astolfi; D Regoli; G Drapeau; A Giachetti
NK-1 receptors and vascular permeability in rat airways.
Annals of the New York Academy of Sciences 1991;632():358-9.
1991: Carlo Alberto Maggi; Riccardo Patacchini; M Astolfi; Paolo Rovero; Sandro Giuliani; A Giachetti
NK-2 receptor agonists and antagonists.
Annals of the New York Academy of Sciences 1991;632():184-91.
1991: Sandro Giuliani; Carlo Alberto Maggi; Riccardo Patacchini; Paolo Santicioli; Damiano Turini; G Barbanti; Paolo Rovero; A Giachetti; A Meli
Tachykinin receptors in the longitudinal and circular muscle of the human ileum.
Advances in experimental medicine and biology 1991;298():249-52.
1990: Massimo Parlani; B Conte; S Majmone; Carlo Alberto Maggi; Paolo Rovero; A Giachetti
The contractile effect of tachykinins on human prostatic urethra: involvement of NK-2 receptors.
The Journal of urology 1990;144(6):1543-5.
1990: Paolo Rovero; R Patacchini; C A Maggi
Structure-activity studies on endothelin (16-21), the C-terminal hexapeptide of the endothelins, in the guinea-pig bronchus.
British journal of pharmacology 1990;101(1):232-4.
1990: Alessandro Lecci; Carlo Alberto Maggi; Paolo Rovero; A Giachetti; A Meli
Effect of endothelin-1, endothelin-3 and C-terminal hexapeptide, endothelin (16-21) on motor activity in rats.
Neuropeptides 1990;16(1):21-4.
1990: Paolo Rovero; V Pestellini; R Patacchini; Sandro Giuliani; C A Maggi; A Meli; A Giachetti
Synthesis and biological activity of NK-2 selective tachykinin antagonists containing D-tryptophan.
Peptides 1990;11(3):619-20.
1990: Carlo Alberto Maggi; Paolo Rovero; Sandro Giuliani; Stefano Evangelista; D Regoli; A Meli
Biological activity of N-terminal fragments of calcitonin gene-related peptide.
European journal of pharmacology 1990;179(1-2):217-9.
1990: Carlo Alberto Maggi; Sandro Giuliani; L Ballati; Paolo Rovero; luigi abelli; Stefano Manzini; A Giachetti; A Meli
In vivo pharmacology of [beta Ala8]neurokinin A-(4-10), a selective NK-2 tachykinin receptor agonist.
European journal of pharmacology 1990;177(1-2):81-6.
1990: Paolo Rovero; V Pestellini; C A Maggi; R Patacchini; D Regoli; A Giachetti
A highly selective NK-2 tachykinin receptor antagonist containing D-tryptophan.
European journal of pharmacology 1990;175(1):113-5.
1990: Carlo Alberto Maggi; Riccardo Patacchini; Sandro Giuliani; Damiano Turini; G Barbanti; Paolo Rovero; A Meli
Motor response of the human isolated small intestine and urinary bladder to porcine neuromedin U-8.
British journal of pharmacology 1990;99(1):186-8.
1989: Carlo Alberto Maggi; Sandro Giuliani; Riccardo Patacchini; Paolo Rovero; A Giachetti; A Meli
The activity of peptides of the endothelin family in various mammalian smooth muscle preparations.
European journal of pharmacology 1989;174(1):23-31.
1989: Carlo Alberto Maggi; Riccardo Patacchini; Paolo Rovero; A Meli
The hamster isolated trachea: a new preparation for studying NK-2 receptors.
European journal of pharmacology 1989;166(3):435-40.
1989: Riccardo Patacchini; Carlo Alberto Maggi; Paolo Rovero; D Regoli; G Drapeau; A Meli
Effect of thiorphan on tachykinin-induced potentiation of nerve-mediated contractions of the rat isolated vas deferens.
The Journal of pharmacology and experimental therapeutics 1989;250(2):678-81.
1989: luigi abelli; V Somma; Carlo Alberto Maggi; D Regoli; M Astolfi; Massimo Parlani; Paolo Rovero; B Conte; A Meli
Effects of tachykinins and selective tachykinin receptor agonists on vascular permeability in the rat lower urinary tract: evidence for the involvement of NK-1 receptors.
Journal of autonomic pharmacology 1989;9(4):253-63.
1989: Carlo Alberto Maggi; Sandro Giuliani; Riccardo Patacchini; Paolo Santicioli; Paolo Rovero; A Giachetti; A Meli
The C-terminal hexapeptide, endothelin-(16-21), discriminates between different endothelin receptors.
European journal of pharmacology 1989;166(1):121-2.
1989: Carlo Alberto Maggi; Riccardo Patacchini; Daniela Renzi; Paolo Santicioli; D Regoli; Paolo Rovero; G Drapeau; Calogero Surrenti; A Meli
Effect of thiorphan on response of the guinea-pig gallbladder to tachykinins.
European journal of pharmacology 1989;165(1):51-61.
1989: Paolo Rovero; V Pestellini; R Patacchini; Sandro Giuliani; Paolo Santicioli; C A Maggi; A Meli; A Giachetti
A potent and selective agonist for NK-2 tachykinin receptor.
Peptides 1989;10(3):593-5.
1989: Paolo Rovero; V Pestellini; Nour-Eddine Rhaleb; SB Dion; N Rouissi; C Tousignant; S Télémaque; G Drapeau; D Regoli
Structure-activity studies of neurokinin A.
Neuropeptides 1989;13(4):263-70.
1989: S Evangelista; I T Lippe; Paolo Rovero; Carlo Alberto Maggi; A Meli
Tachykinins protect against ethanol-induced gastric lesions in rats.
Peptides 1989;10(1):79-81.
1989: Paolo Rovero; V Pestellini; R Patacchini; Paolo Santicioli; C A Maggi; A Meli
Conformationally constrained tachykinins: N-methylated analogues of neurokinin A.
Biopolymers 1989;28(1):65-7.
1989: Carlo Alberto Maggi; Riccardo Patacchini; Paolo Santicioli; Damiano Turini; G Barbanti; Patrizia Beneforti; Paolo Rovero; A Meli
Further studies on the motor response of the human isolated urinary bladder to tachykinins, capsaicin and electrical field stimulation.
General pharmacology 1989;20(5):663-9.
1988: Sandro Giuliani; Carlo Alberto Maggi; Paolo Rovero; A Meli
Neurokinins induce a relaxation of the rat duodenum "in vivo" by activating postganglionic sympathetic elements in prevertebral ganglia: involvement of an NK-2 type of neurokinin receptor.
The Journal of pharmacology and experimental therapeutics 1988;246(1):322-7.
1988: Carlo Alberto Maggi; Massimo Parlani; M Astolfi; Paolo Santicioli; Paolo Rovero; luigi abelli; V Somma; Sandro Giuliani; D Regoli; Riccardo Patacchini
Neurokinin receptors in the rat lower urinary tract.
The Journal of pharmacology and experimental therapeutics 1988;246(1):308-15.
1988: Stefano Manzini; S Conti; C A Maggi; Paolo Rovero; L Ballati
Neurokinin A-(4-10): a potent bronchospastic agent virtually devoid of sialologic properties in anaesthetized guinea-pigs.
European journal of pharmacology 1988;148(3):475-8.
1988: Carlo Alberto Maggi; Paolo Santicioli; Riccardo Patacchini; M Cellerini; Damiano Turini; G Barbanti; Patrizia Beneforti; Paolo Rovero; A Meli
Contractile response of the human isolated urinary bladder to neurokinins: involvement of NK-2 receptors.
European journal of pharmacology 1988;145(3):335-40.
1987: Paolo Rovero; V Pestellini; R Patacchini; Paolo Santicioli; C A Maggi; A Meli
Synthesis and biological activity of N-methylated analogues of neurokinin A.
Neuropeptides 1987;10(4):355-9.